Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Finance.
Press releases published on May 12, 2025
ISS North America Appoints Brad Lurie as Vice President of Sales, East Region
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- ISS, a global leader in workplace experience and facility management and one of the largest employers in the world with 320,000 employees, has appointed seasoned executive Brad Lurie as Vice President of Sales, …
Argo Expands Strategy with Graphene Leaders Canada to Explore Graphene-Infused Asphalt Innovations
GlobeNewswire
·
May 12, 2025
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Argo Living Soils Corp. (CSE: ARGO) (OTCQB: ARLSF) (FRANKFURT: 94Y0) (“Argo” or the “Company”) is pleased to announce that, following our May 5, 2025, news release regarding the research and …
ASUS Republic of Gamers Strengthens Partnership with Team NRG
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- ASUS Republic of Gamers (ROG) and NRG today announced the expansion of their partnership. NRG, an American esports team, will benefit from a full range of ROG laptops, desktops, and handheld gaming devices — …
CBAK Energy to Report First Quarter 2025 Unaudited Financial Results on Monday, May 19, 2025
GlobeNewswire
·
May 12, 2025
DALIAN, China, May 12, 2025 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider in China, today announced that it will report …
Advent Technologies Announces Dr. Ryan Pavlicek as General Manger of Livermore Facility
GlobeNewswire
·
May 12, 2025
LIVERMORE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Dr. Ryan Pavlicek has …
Brain Cancer Canada Grants McGill University $100,000 to Advance Pediatric Brain Cancer Research
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to award a $100,000 pediatric research grant to Dr. Carl Ernst, professor and scientist at McGill University, and his team. The work explores a gene therapy treatment for pediatric …
Concentrix to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 12, 2025
NEWARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced that members of its senior management team will be participating in the following upcoming conferences: J.P. …
AAA-ICDR® Announces New Board Leadership and New Board Members to Advance the Strategic Transformation of ADR
GlobeNewswire
·
May 12, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- The American Arbitration Association-International Centre for Dispute Resolution® (AAA-ICDR), the global leader in alternative dispute resolution (ADR), is excited to announce new leadership for its Board of …
Granite Creek Names Agribusiness Leader Matt Morgan Director of Business Development
GlobeNewswire
·
May 12, 2025
CHICAGO, May 12, 2025 (GLOBE NEWSWIRE) -- Granite Creek Capital Partners, L.L.C., a Chicago-based private investment firm, today announced the appointment of Matt Morgan as Director of Business Development. With more than 20 years of leadership experience …
A Decade of Dapper: Movember and the Distinguished Gentleman’s Ride Gear Up to Celebrate 10 Years of Riding Together for Men’s Health
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- A global movement with a decade of impact! This year, Movember and The Distinguished Gentleman’s Ride (DGR) proudly mark 10 years of partnership, riding to raise vital funds that lift the profile of men’s health …
Orbit International Corp. Reports 2025 First Quarter Results
GlobeNewswire
·
May 12, 2025
First Quarter 2025 Net Loss of $2,152,000 ($0.65 loss per share) v. Net Loss of $751,000 ($0.22 loss per share) in Prior Year Comparable Period First Quarter 2025 EBITDA, as adjusted, was a loss of $1,949,000 ($0.59 loss per share) v. loss of $551,000 ($0. …
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
GlobeNewswire
·
May 12, 2025
PALM BEACH, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial Intelligence (AI) is becoming more essential in the medical markets every day, it seems. AI algorithms have demonstrated the capability to analyze vast amounts …
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
GlobeNewswire
·
May 12, 2025
PORTLAND, Maine, May 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
DP World unterschreibt Vertrag für den Bau eines 760 Mio. $ teuren Hafens und einer Freihandelszone in der Dominikanischen Republik
GlobeNewswire
·
May 12, 2025
SANTO DOMINGO, Dominikanische Republik, May 12, 2025 (GLOBE NEWSWIRE) -- DP World hat mit der Regierung der Dominikanischen Republik eine wegweisende Absichtserklärung (Memorandum of Understanding, MoU) über 760 Mio. $ unterzeichnet, um den Hafen von …
DP World signe un accord à 760 millions de dollars pour développer un port et une zone de libre-échange en République dominicaine
GlobeNewswire
·
May 12, 2025
SAINT-DOMINGUE, République dominicaine, 12 mai 2025 (GLOBE NEWSWIRE) -- DP World a signé un protocole d’accord majeur d’une valeur de 760 millions USD avec le gouvernement dominicain, en vue d’agrandir le port de Caucedo et sa zone de libre-échange — une …
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
GlobeNewswire
·
May 12, 2025
Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested Enrollment and dosing underway in Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin for the treatment of R/R …
Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th
GlobeNewswire
·
May 12, 2025
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs …
First Pacific to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th
GlobeNewswire
·
May 12, 2025
HONG KONG, May 12, 2025 (GLOBE NEWSWIRE) -- First Pacific Company Limited (Hong Kong: 00142, ADR: FPAFY) based in Hong Kong and focused on domestic defensive businesses in the fast-growing region of Southeast Asia, today announced that Associate Director …
Barnes & Noble Education Announces Surge in New Campus Store Partnerships
GlobeNewswire
·
May 12, 2025
BASKING RIDGE, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Barnes …
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2025 Earnings Release Conference Call
GlobeNewswire
·
May 12, 2025
DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results for the fiscal fourth quarter and year ended March 31, 2025, on Thursday, May 22, 2025, before the market opens. The Company …